A 58-year-old man with known cirrhosis presents with altered mental status and confusion. His EEG shows the pattern marked **A** in the diagram — generalized, bilaterally symmetric waves with a characteristic three-phase morphology (initial small negative deflection, large positive deflection, final negative deflection), occurring at 1.5–2.5 Hz with frontal predominance and anterior-to-posterior lag. Serum ammonia is elevated at 120 µmol/L. Which of the following is the most appropriate NEXT STEP in management?
A. Initiate lactulose and rifaximin; treat underlying hepatic encephalopathy
B. Perform lumbar puncture to rule out meningitis
C. Administer IV benzodiazepines followed by continuous EEG monitoring for sustained improvement
D. Start phenytoin or levetiracetam empirically for presumed nonconvulsive status epilepticus
Explanation
Why "Initiate lactulose and rifaximin; treat underlying hepatic encephalopathy" is right
The pattern marked A — triphasic waves (TWs) with the described three-phase morphology, frontal predominance, anterior-to-posterior lag, and 1.5–2.5 Hz frequency — is the characteristic EEG hallmark of toxic-metabolic encephalopathy, classically hepatic encephalopathy in a cirrhotic patient with hyperammonemia. Per Niedermeyer's Electroencephalography 7e, the management of TWs is NOT empiric antiseizure therapy, but rather treatment of the underlying metabolic cause. In hepatic encephalopathy, this means ammonia-lowering therapy with lactulose and rifaximin, plus supportive care. The EEG pattern itself is not an indication for antiepileptic drugs unless nonconvulsive status epilepticus (NCSE) cannot be excluded clinically.
Why each distractor is wrong
Start phenytoin or levetiracetam empirically for presumed nonconvulsive status epilepticus: Empiric antiseizure medication is NOT indicated for triphasic waves. While NCSE can mimic metabolic TWs, the clear triphasic morphology, frontal predominance with AP lag, elevated ammonia, and cirrhotic background all favor metabolic encephalopathy. Antiepileptic drugs do not address the underlying ammonia excess and delay definitive treatment.
Perform lumbar puncture to rule out meningitis: The EEG pattern is diagnostic of metabolic encephalopathy, not infection. The patient has a clear metabolic substrate (cirrhosis, elevated ammonia) and no clinical features suggesting CNS infection (fever, neck stiffness, CSF pleocytosis would be expected). LP is unnecessary and delays ammonia-lowering therapy.
Administer IV benzodiazepines followed by continuous EEG monitoring for sustained improvement: While a benzodiazepine trial can help distinguish metabolic TWs from NCSE, the clinical and EEG context here is unambiguous for hepatic encephalopathy. Benzodiazepines provide only temporary symptomatic relief and do not treat hyperammonemia. The key diagnostic feature of metabolic TWs is that they re-emerge after benzodiazepine effect wears off if the metabolic cause is not addressed — this is NOT the goal of management.
High-YieldNEET PG
Triphasic waves = metabolic encephalopathy (especially hepatic); treat the cause (ammonia, glucose, electrolytes, offending drugs), not the EEG pattern. Antiepileptic drugs are not first-line unless NCSE is clinically suspected.
Niedermeyer's Electroencephalography, 7th edition
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
